Skip to main content
. 2022 Feb 9;157(4):335–342. doi: 10.1001/jamasurg.2021.7554

Figure 1. Patient Flow Diagram.

Figure 1.

MeMaLoc indicates Magnetic Seed Localization for Melanoma; OpACIN, Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients; OpACIN-neo, Optimal Neo-Adjuvant Combination Scheme of Ipilimumab and Nivolumab; TLND, therapeutic lymph node dissection.